A S Kubasch - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

A S Kubasch

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 12, 2017

[Oculocutaneous and ocular albinism]A S Kubasch, M Meurer

Clinical Immunology (Orlando, Fla.)|September 26, 2015

Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and releaseS R Hofmann, A S Kubasch, C Ioannidis, et al.

Leukemia|September 22, 2023

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trialA S Kubasch, P Peterlin, T Cluzeau, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|October 12, 2017

[Oculocutaneous and ocular albinism]A S Kubasch, M Meurer

Clinical Immunology (Orlando, Fla.)|September 26, 2015

Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1β expression and releaseS R Hofmann, A S Kubasch, C Ioannidis, et al.

Leukemia|September 22, 2023

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trialA S Kubasch, P Peterlin, T Cluzeau, et al.

Pageof 1